Niagen Bioscience, Inc. - Common Stock (NAGE)

72 filings reported holding NAGE - Niagen Bioscience, Inc. - Common Stock as of Q3 2018.
Niagen Bioscience, Inc. - Common Stock (NAGE) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 9,540,520 shares of 79,794,643 outstanding shares and own 11.96% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,913,433 shares), ICONIQ Capital, LLC (1,707,317 shares), Vanguard Group Inc (1,572,078 shares), Tieton Capital Management, LLC (1,081,245 shares), STATE STREET CORP (565,888 shares), NORTHERN TRUST CORP (406,427 shares), GEODE CAPITAL MANAGEMENT, LLC (329,362 shares), FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. (268,221 shares), UBS Group AG (145,062 shares), and Bank of New York Mellon Corp (104,402 shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.